Key result
This review outlines current recommendations and analyzes comparative studies examining anticoagulation versus antiplatelet therapy for thromboprophylaxis after bioprosthetic aortic valve replacement.
Why the study?
Does anticoagulation therapy compared to antiplatelet therapy improve outcomes in patients following bioprosthetic aortic valve replacement?
Does anticoagulation therapy compared to antiplatelet therapy improve outcomes in patients following bioprosthetic aortic valve replacement?
This review underscores the ongoing controversy and lack of robust evidence regarding the optimal choice between anticoagulation and antiplatelet therapy for thromboprophylaxis after bioprosthetic AVR.
No takes yet. Share an insight, caveat, or question.
Individualized risk-benefit assessment remains essential after bioprosthetic AVR; level 4 data leaves optimal regimen open.
Mydin et al. (2012) conducted a review in Bioprosthetic aortic valve replacement. Anticoagulation vs. Antiplatelet therapy was evaluated. This review outlines current recommendations and analyzes comparative studies examining anticoagulation versus antiplatelet therapy for thromboprophylaxis after bioprosthetic aortic valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: